Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00086658
Recruitment Status : Completed
First Posted : July 9, 2004
Last Update Posted : April 17, 2015
Information provided by (Responsible Party):